Oslo Science City/LinkedIn
May 25, 2025, 11:00
Oslo Science City has Launched a Strategic Partner Program with Eight Leading Global Pharmaceutical Companies
“Launch of strategic partner program.
Together with our members, Oslo Science City has launched a strategic partner program with eight leading global pharmaceutical companies: Novartis, GE HealthCare, GSK, Novo Nordisk, Thermo Fisher Scientific, AstraZeneca, Bayer and Roche.
“It is incredibly inspiring to see how the partner programme in Oslo Science City realises the purpose of facilitating active interaction between leading research environments, students, business actors and the public sector,” says Bente Mikkelsen, former director of the WHO and the South-Eastern Norway Regional Health Authority and special adviser for Oslo Science City.
Read article here.”
More posts featuring Oslo Science City.
AstraZeneca
Bayer
Bente Mikkelsen
cancer
fight against cancer
GE HealthCare
Global fight against cancer
Global Pharmaceutical Companies
GSK
Novartis
Novo Nordisk
OncoDaily
Oncology
Oslo Science City
Roche
South-Eastern Norway Regional Health Authority
Strategic Partner Program
Thermo Fisher Scientific
WHO
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 5, 2025, 20:31
Jul 5, 2025, 20:15
Jul 5, 2025, 20:00
Jul 5, 2025, 19:18
Jul 5, 2025, 18:52
Jul 5, 2025, 18:38